A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-06-30) →
What happened
Aligned Genetics disclosed a plan to sell treasury shares worth US$399K, about 1.6% of its market value.
For context, this equals about 1.6% of the company's market value.
| Disposal amount | US$399K |
|---|---|
| vs. market value | 1.6% |
| Filed | 2026-05-29, Material event report (treasury share disposal) |
| Source | DART rcept 20260529001640 → open original filing |
Versions of this filing
- 2026-05-29Original (this page)
- 2026-06-30Amendment 1
Source: DART. Information only, not investment advice.

